D DeLair, E Oliva, M Köbel, A Macias… - … American journal of …, 2011 - journals.lww.com Establishing a diagnosis of ovarian clear cell carcinoma (O-CCC) can be subject to significant interobserver variation. Accurately diagnosing this tumor is important because of its chemoresistance and reported association with Lynch syndrome. The spectrum of the morphologic features ... Cited by 6 - Related articles - All 5 versions
S Mabuchi, T Hisamatsu, C Kawase… - Clinical Cancer …, 2011 - AACR Experimental Design: Using 6 human ovarian cancer cell lines (3 CCC and 3 serous adenocarcinomas), the antitumor effects of trabectedin were examined in vitro, and we compared its activity according to histology. We next examined the antitumor activity of trabectedin in ... Related articles - All 3 versions
D Maeda, X Chen, B Guan… - International Journal …, 2011 - journals.lww.com ... Ovarian clearcellcarcinoma (CCC) represents less than 10% of ovarian cancers in the United States, but occurs more frequently in Asian women ... marker of reduced disease-specific survival in CCC, but not in high-grade serous or endometrioid carcinomas of the ovary ( 11 ). ... Cited by 1 - Related articles - All 5 versions
J Al-Barrak, JL Santos, A Tinker, P Hoskins… - Gynecologic …, 2011 - Elsevier ... Research highlights. ► Among patients with advanced clearcellcarcinoma of ovary (CCC), chemotherapy provides a modest palliative benefits and careful monitoring is necessary in order to determine the benefit to risk ratio. ... Related articles - All 2 versions
M Takano, Y Kikuchi, K Kudoh, T Goto… - International Journal of …, 2011 - Springer Abstract Clear cell carcinoma (CCC) of the ovary is well-known to be chemotherapy resistant compared with other histologic subtypes. An inhibitor against the mam- malian target of rapamycin, temsirolimus (TEM) has been reported to be effective in renal CCC. Therefore, ... Related articles - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
